A 584 bp deletion in CTRB2 inhibits chymotrypsin B2 activity and secretion and confers risk of pancreatic cancer

PanScan Consortium, PanC4 Consortium

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A 584 bp deletion in CTRB2 inhibits chymotrypsin B2 activity and secretion and confers risk of pancreatic cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences